Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
63
-
Shares change
-
0
-
Total reported value, excl. options
-
$839
-
Price
-
$13.32
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2024
2 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q4 2024.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63 shares
of 8.56M outstanding shares and own 0% of the company stock.
Largest 2 shareholders include EverSource Wealth Advisors, LLC (35 shares) and Alexis Investment Partners, LLC (28 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.